STOCK TITAN

[8-K] NioCorp Developments Ltd. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Colony Bankcorp Inc. (CBAN) Form 4 highlights: Director Matthew D. Reed reported the grant of 969 restricted shares on 07/15/2025. Following the award, he now directly owns 16,736 common shares, up roughly 6% from the pre-grant level (~15,767). In addition, Reed holds 448 shares indirectly through an IRA for Kennedy K. Reed. No derivative securities, sales, or open-market purchases were disclosed.

The filing reflects a routine equity-based compensation grant and modestly increases insider ownership, which can align director incentives with shareholder interests. However, because the shares were granted (not purchased with personal funds), the transaction’s immediate signaling value is limited. No other material events, financial metrics, or changes to ownership structure were reported.

Colony Bankcorp Inc. (CBAN) Modulo 4 evidenzia: Il direttore Matthew D. Reed ha dichiarato la concessione di 969 azioni vincolate il 15/07/2025. A seguito dell'assegnazione, ora possiede direttamente 16.736 azioni ordinarie, con un aumento di circa il 6% rispetto al livello precedente (~15.767). Inoltre, Reed detiene 448 azioni indirettamente tramite un IRA per Kennedy K. Reed. Non sono stati segnalati titoli derivati, vendite o acquisti sul mercato aperto.

La comunicazione riflette una consueta assegnazione di compensi basati su azioni e aumenta moderatamente la proprietà interna, potenzialmente allineando gli interessi del direttore con quelli degli azionisti. Tuttavia, poiché le azioni sono state assegnate (non acquistate con fondi personali), il valore segnaletico immediato della transazione è limitato. Non sono stati riportati altri eventi rilevanti, metriche finanziarie o cambiamenti nella struttura proprietaria.

Colony Bankcorp Inc. (CBAN) Formulario 4 destaca: El director Matthew D. Reed reportó la concesión de 969 acciones restringidas el 15/07/2025. Tras la adjudicación, ahora posee directamente 16,736 acciones comunes, un aumento de aproximadamente el 6% respecto al nivel previo (~15,767). Además, Reed posee 448 acciones indirectamente a través de una IRA para Kennedy K. Reed. No se divulgaron valores derivados, ventas ni compras en el mercado abierto.

La presentación refleja una concesión rutinaria de compensación basada en acciones y aumenta modestamente la propiedad de los directivos, lo que puede alinear los incentivos del director con los intereses de los accionistas. Sin embargo, dado que las acciones fueron concedidas (no compradas con fondos personales), el valor inmediato de la señal de la transacción es limitado. No se reportaron otros eventos materiales, métricas financieras ni cambios en la estructura de propiedad.

Colony Bankcorp Inc. (CBAN) Form 4 주요 내용: 이사 Matthew D. Reed가 2025년 7월 15일에 969주의 제한 주식 부여를 보고했습니다. 이번 수여로 그는 현재 직접 16,736주의 보통주를 보유하고 있으며, 수여 전 약 6% 증가한 수치(~15,767)입니다. 또한 Reed는 Kennedy K. Reed를 위한 IRA를 통해 간접적으로 448주를 보유 중입니다. 파생 증권, 매도 또는 공개 시장 매수 내역은 보고되지 않았습니다.

이번 보고는 일상적인 주식 기반 보상 부여를 반영하며, 내부자 소유 지분을 소폭 증가시켜 이사의 동기와 주주 이익을 일치시킬 수 있습니다. 다만, 주식이 부여된 것이지 개인 자금으로 구매된 것이 아니므로 거래의 즉각적인 신호 가치는 제한적입니다. 기타 중요한 사건, 재무 지표 또는 소유 구조 변경 사항은 보고되지 않았습니다.

Colony Bankcorp Inc. (CBAN) Formulaire 4 points clés : Le directeur Matthew D. Reed a déclaré l’attribution de 969 actions restreintes le 15/07/2025. Suite à cette attribution, il possède désormais directement 16 736 actions ordinaires, soit une augmentation d’environ 6 % par rapport au niveau avant attribution (~15 767). De plus, Reed détient 448 actions indirectement via un IRA au nom de Kennedy K. Reed. Aucun titre dérivé, vente ou achat sur le marché ouvert n’a été divulgué.

Le dépôt reflète une attribution de rémunération en actions de routine et augmente modestement la détention d’initiés, ce qui peut aligner les incitations du directeur sur les intérêts des actionnaires. Cependant, comme les actions ont été attribuées (et non achetées avec des fonds personnels), la valeur indicative immédiate de la transaction est limitée. Aucun autre événement important, indicateur financier ou changement dans la structure de propriété n’a été rapporté.

Colony Bankcorp Inc. (CBAN) Formular 4 Highlights: Direktor Matthew D. Reed meldete die Gewährung von 969 eingeschränkten Aktien am 15.07.2025. Nach der Zuteilung besitzt er nun direkt 16.736 Stammaktien, was einem Anstieg von etwa 6 % gegenüber dem vorherigen Bestand (~15.767) entspricht. Zusätzlich hält Reed 448 Aktien indirekt über ein IRA für Kennedy K. Reed. Es wurden keine Derivate, Verkäufe oder Käufe am offenen Markt gemeldet.

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider und erhöht moderat den Insiderbesitz, was die Interessen des Direktors mit denen der Aktionäre in Einklang bringen kann. Da die Aktien jedoch gewährt wurden (nicht mit eigenen Mitteln gekauft), ist der unmittelbare Signalisierungswert der Transaktion begrenzt. Es wurden keine weiteren wesentlichen Ereignisse, Finanzkennzahlen oder Änderungen in der Eigentümerstruktur gemeldet.

Positive
  • Director ownership rises ~6%, marginally improving management-shareholder alignment
Negative
  • None.

Insights

TL;DR: Routine restricted-stock grant lifts director’s stake 6%; alignment positive but signal limited versus open-market buy.

Restricted stock awards are standard board compensation. Reed’s direct ownership rises to 16,736 shares, keeping directors’ interests aligned with investors. Because no cash outlay was made, market shouldn’t infer the same confidence as an outright purchase. No red flags—no sales, pledges, or derivative positions—so governance risk remains low. Impact: neutral-positive.

TL;DR: Small, non-cash insider acquisition; negligible valuation impact.

The 969-share grant equates to <1% of CBAN’s ~9.0 m shares outstanding, therefore immaterial to float or supply/demand. Because the stock was awarded, not bought, it doesn’t convey incremental bullish sentiment. I view the event as routine and non-impactful for portfolio positioning.

Colony Bankcorp Inc. (CBAN) Modulo 4 evidenzia: Il direttore Matthew D. Reed ha dichiarato la concessione di 969 azioni vincolate il 15/07/2025. A seguito dell'assegnazione, ora possiede direttamente 16.736 azioni ordinarie, con un aumento di circa il 6% rispetto al livello precedente (~15.767). Inoltre, Reed detiene 448 azioni indirettamente tramite un IRA per Kennedy K. Reed. Non sono stati segnalati titoli derivati, vendite o acquisti sul mercato aperto.

La comunicazione riflette una consueta assegnazione di compensi basati su azioni e aumenta moderatamente la proprietà interna, potenzialmente allineando gli interessi del direttore con quelli degli azionisti. Tuttavia, poiché le azioni sono state assegnate (non acquistate con fondi personali), il valore segnaletico immediato della transazione è limitato. Non sono stati riportati altri eventi rilevanti, metriche finanziarie o cambiamenti nella struttura proprietaria.

Colony Bankcorp Inc. (CBAN) Formulario 4 destaca: El director Matthew D. Reed reportó la concesión de 969 acciones restringidas el 15/07/2025. Tras la adjudicación, ahora posee directamente 16,736 acciones comunes, un aumento de aproximadamente el 6% respecto al nivel previo (~15,767). Además, Reed posee 448 acciones indirectamente a través de una IRA para Kennedy K. Reed. No se divulgaron valores derivados, ventas ni compras en el mercado abierto.

La presentación refleja una concesión rutinaria de compensación basada en acciones y aumenta modestamente la propiedad de los directivos, lo que puede alinear los incentivos del director con los intereses de los accionistas. Sin embargo, dado que las acciones fueron concedidas (no compradas con fondos personales), el valor inmediato de la señal de la transacción es limitado. No se reportaron otros eventos materiales, métricas financieras ni cambios en la estructura de propiedad.

Colony Bankcorp Inc. (CBAN) Form 4 주요 내용: 이사 Matthew D. Reed가 2025년 7월 15일에 969주의 제한 주식 부여를 보고했습니다. 이번 수여로 그는 현재 직접 16,736주의 보통주를 보유하고 있으며, 수여 전 약 6% 증가한 수치(~15,767)입니다. 또한 Reed는 Kennedy K. Reed를 위한 IRA를 통해 간접적으로 448주를 보유 중입니다. 파생 증권, 매도 또는 공개 시장 매수 내역은 보고되지 않았습니다.

이번 보고는 일상적인 주식 기반 보상 부여를 반영하며, 내부자 소유 지분을 소폭 증가시켜 이사의 동기와 주주 이익을 일치시킬 수 있습니다. 다만, 주식이 부여된 것이지 개인 자금으로 구매된 것이 아니므로 거래의 즉각적인 신호 가치는 제한적입니다. 기타 중요한 사건, 재무 지표 또는 소유 구조 변경 사항은 보고되지 않았습니다.

Colony Bankcorp Inc. (CBAN) Formulaire 4 points clés : Le directeur Matthew D. Reed a déclaré l’attribution de 969 actions restreintes le 15/07/2025. Suite à cette attribution, il possède désormais directement 16 736 actions ordinaires, soit une augmentation d’environ 6 % par rapport au niveau avant attribution (~15 767). De plus, Reed détient 448 actions indirectement via un IRA au nom de Kennedy K. Reed. Aucun titre dérivé, vente ou achat sur le marché ouvert n’a été divulgué.

Le dépôt reflète une attribution de rémunération en actions de routine et augmente modestement la détention d’initiés, ce qui peut aligner les incitations du directeur sur les intérêts des actionnaires. Cependant, comme les actions ont été attribuées (et non achetées avec des fonds personnels), la valeur indicative immédiate de la transaction est limitée. Aucun autre événement important, indicateur financier ou changement dans la structure de propriété n’a été rapporté.

Colony Bankcorp Inc. (CBAN) Formular 4 Highlights: Direktor Matthew D. Reed meldete die Gewährung von 969 eingeschränkten Aktien am 15.07.2025. Nach der Zuteilung besitzt er nun direkt 16.736 Stammaktien, was einem Anstieg von etwa 6 % gegenüber dem vorherigen Bestand (~15.767) entspricht. Zusätzlich hält Reed 448 Aktien indirekt über ein IRA für Kennedy K. Reed. Es wurden keine Derivate, Verkäufe oder Käufe am offenen Markt gemeldet.

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider und erhöht moderat den Insiderbesitz, was die Interessen des Direktors mit denen der Aktionäre in Einklang bringen kann. Da die Aktien jedoch gewährt wurden (nicht mit eigenen Mitteln gekauft), ist der unmittelbare Signalisierungswert der Transaktion begrenzt. Es wurden keine weiteren wesentlichen Ereignisse, Finanzkennzahlen oder Änderungen in der Eigentümerstruktur gemeldet.

false 0001512228 A1 0001512228 2025-07-18 2025-07-18 0001512228 NB:CommonSharesWithoutParValueMember 2025-07-18 2025-07-18 0001512228 NB:WarrantsEachExercisableFor1.11829212CommonSharesMember 2025-07-18 2025-07-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 18, 2025

 

 

 

NioCorp Developments Ltd.

 

(Exact name of registrant as specified in its charter)

 

 

 

British Columbia, Canada
(State or other jurisdiction
of incorporation)
001-41655
(Commission File Number)
98-1262185
(IRS Employer
Identification No.)

7000 South Yosemite Street, Suite 115
Centennial, Colorado 80112
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (720) 334-7066

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, without par value NB The Nasdaq Stock Market LLC
Warrants, each exercisable for 1.11829212 Common Shares NIOBW The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 Emerging growth company         

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

Item 8.01Other Events.

NioCorp Developments Ltd. is filing herewith the following exhibits to its Registration Statement on Form S-3 (File No. 333-280176):

1.Placement Agency Agreement, dated as of July 17, 2025, by and between NioCorp Development Ltd. and Maxim Group LLC; and
2.Opinion and Consent of Blake, Cassels & Graydon LLP.

 

Item 9.01Financial Statements and Exhibits.

(d) Exhibits

Exhibit
Number
Description
1.1* Placement Agency Agreement, dated as of July 17, 2025, by and between NioCorp Development Ltd. and Maxim Group LLC
5.1 Opinion of Blake, Cassels & Graydon LLP
23.1 Consent of Blake, Cassels & Graydon LLP (included in Exhibit 5.1)
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Certain of the exhibits to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The registrant agrees to furnish a copy of all omitted exhibits to the SEC upon its request. 

 

 
 

signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 18, 2025

  NIOCORP DEVELOPMENTS LTD.
  By: /s/ Neal S. Shah
  Name: Neal S. Shah
  Title: Chief Financial Officer

 

 

 

 

Niocorp Developm

NASDAQ:NB

NB Rankings

NB Latest News

NB Stock Data

220.51M
69.62M
6.6%
6.79%
1.59%
Other Industrial Metals & Mining
Metal Mining
Link
United States
CENTENNIAL